Cuzzocrea Salvatore, Rossi Antonietta, Serraino Ivana, Di Paola Rosanna, Dugo Laura, Genovese Tiziana, Britti Domenico, Sciarra Giuseppe, De Sarro Angelina, Caputi Achille P, Sautebin Lidia
Department of Clinical and Experimental Medicine and Pharmacology, Torre Biologica, Policlinico Universitario, 98123 Messina, Italy.
Intensive Care Med. 2004 Oct;30(10):1935-43. doi: 10.1007/s00134-004-2353-y. Epub 2004 Jul 6.
This study investigated the role of 5-lipoxygenase in the pathogenesis of multiple organ failure (MOF) induced by zymosan.
Male mice with a targeted disruption of the 5-lipoxygenase gene (5-LOKO) and littermate wild-type (WT) controls (5-LOWT) were used to evaluate the role of 5-lipoxygenase (5-LO) in the pathogenesis of MOF.
University research laboratory.
MOF was induced by peritoneal injection of zymosan (500 mg/kg i.p. as a suspension in saline) in 5-LOWT and in 5-LOKO mice. MOF was assessed 18 h after administration of zymosan and monitored for 12 days (for loss of body weight and mortality).
A severe inflammatory process induced by zymosan administration in WT mice coincided with the damage of lung and small intestine, as assessed by histological examination. Myeloperoxidase activity indicative of neutrophil infiltration and lipid peroxidation were significantly increased in zymosan-treated WT mice. Zymosan in the WT mice also induced a significant increase in the plasma level of nitrite/nitrate. Immunohistochemical examination demonstrated a marked increase in the immunoreactivity to ICAM-1 and P-selectin in the lung and intestine of zymosan-treated WT mice. In contrast, the degree of (a) peritoneal inflammation and tissue injury, (b) upregulation/expression of P-selectin and ICAM-1, and (c) neutrophil infiltration were markedly reduced in intestine and lung tissue obtained from zymosan-treated 5-LO deficient mice. Zymosan-treated 5-LOKO showed also a significantly decreased mortality.
These findings clearly demonstrate that 5-LO exerts a role in zymosan-induced nonseptic shock.
本研究调查5-脂氧合酶在酵母聚糖诱导的多器官功能衰竭(MOF)发病机制中的作用。
使用5-脂氧合酶基因靶向破坏的雄性小鼠(5-LOKO)和同窝野生型(WT)对照小鼠(5-LOWT)来评估5-脂氧合酶(5-LO)在MOF发病机制中的作用。
大学研究实验室。
通过腹腔注射酵母聚糖(500 mg/kg,腹腔注射,以生理盐水悬浮液形式)在5-LOWT和5-LOKO小鼠中诱导MOF。在给予酵母聚糖后18小时评估MOF,并监测12天(观察体重减轻和死亡率)。
组织学检查显示,野生型小鼠中酵母聚糖给药诱导的严重炎症过程与肺和小肠损伤同时发生。在酵母聚糖处理的野生型小鼠中,指示中性粒细胞浸润和脂质过氧化的髓过氧化物酶活性显著增加。野生型小鼠中的酵母聚糖还诱导血浆中亚硝酸盐/硝酸盐水平显著升高。免疫组织化学检查表明,酵母聚糖处理的野生型小鼠的肺和肠道中ICAM-1和P-选择素的免疫反应性显著增加。相比之下,从酵母聚糖处理的5-LO缺陷小鼠获得的肠和肺组织中,(a)腹膜炎症和组织损伤程度、(b)P-选择素和ICAM-1的上调/表达以及(c)中性粒细胞浸润明显减少。酵母聚糖处理的5-LOKO小鼠的死亡率也显著降低。
这些发现清楚地表明5-LO在酵母聚糖诱导的非感染性休克中发挥作用。